Ratiometric pH-Responsive F-19 Magnetic Resonance Imaging Contrast Agents Based on Hydrazone Switches

Ratiometric pH-Responsive 19F Magnetic Resonance Imaging Contrast Agents Based on Hydrazone Switches Dawid Janasik, Krzysztof Jasinski, Władysław P. Węglarz, Ivan Nemec, Pawel Jewula, and Tomasz Krawczyk* Cite This: Anal. Chem. 2022, 94, 3427−3431 Read Online ACCESS Metrics & More Article Recommendations * sıSupporting Information ABSTRACT: Hydrazone-based molecular switches serve as efficient ratiometric pH-sensitive agents that can be tracked with 19F NMR/MRI and 1H NMR. Structural changes induced between pH 3 and 4 lead to signal appearance and disappearance at 1H and 19F NMR spectra allowing ratiometric pH measurements. The most pronounced are resonances of the CF3group shifted by 1.8 ppm with 19F NMR and a hydrazone proton shifted by 2 ppm with 1H NMR. The measurement of pH is a fundamental aspect of chemical research. Many tools have been developed for this purpose, and visual indicators 1 and pH-sensitive electrodes 2 are commonplace in almost every laboratory. More sophisticated techniques were proposed for medicinal diagnostic, where a deviation from physiological pH indicates various pathological changes. For example, gastroesophageal reflux disease manifests an esophageal pH < 4 3,4 while solid tumors are more acidic (pH 6.2−7.0) than normal tissue (pH ∼7.5). 5,6 Very low pH is also observed during cellular studies of lysosomes 4.0−5.0. 7,8 The procedures used for pH measurements in medicine rely on microelectrodes and several imaging techniques such as electron paramagnetic resonance (EPR), positron emission tomography (PET), photoacoustic imaging (PAI), and magnetic resonance imaging (MRI). 9 MRI is a noninvasive diagnostic tool for soft tissues that uses the magnetic properties of the 1H nucleus. It is one of the most widely used imaging procedures in medicine and offers excellent spatial resolution and unlimited penetration depth and provides knowledge that cannot be accessed by other means. 10,11 In order to improve the quality of the images, 19F MRI has been extensively investigated as a complementary modality that allows so-called hot spot imaging. 12,13 Since 19F atoms are not present in soft tissues, this modality allows for the accurate representation of the targeted organ without background signals; however, it requires the introduction of an appropriate contrast agent containing 19F nuclei into the organism. 14 Regarding the 19F NMR or MRI as an aid in pH measurements, several molecular probes have been developed. The earliest reports concerned fluorinated aniline derivatives, whose mechanism of action was based on protonation of the aniline nitrogen, which changed the chemical shift of the fluorine atom. 15−17 Other concepts utilized PEGylated nanogels containing perfluorocarbons, 18 C6F6-loaded Au-fluorescent mesoporous silica nanoparticles, 19 or copolymers. 20−23 In those cases, the mechanism of pH-depended signal changes was either based on the reversible volume phase transition of the nanogel, which emitted an 19F NMR signal, or the irreversible decomposition of the capsule under the influence of pH and the release of fluoroorganic groups, respectively. 24 In each case, a single 19F signal with a pH-dependent chemical shift was observed. A probe displaying two separate signals with pH-dependent integral ratios (allowing internal reference and ratiometric measurements) would be more convenient for diagnostic purposes. Hydrazone-based molecular switches could be used in such a role. Molecular switches are usually defined as molecules that can reversibly transform between two (or more) thermodynamically stable states. 25,26 Such compounds are sensitive to external stimuli such as light, pH, or electric current and include photochromic switches, host−guest switches, and rotaxanes. 27−29 The main applications of molecular switches is expected to include molecular electronics (high-density data storage) or organic diodes. 30 They have been also reported as chemosensors or fluorescence imaging agents. 31,32 Here, we demonstrate the first application of ratiometric reversible hydrazone-based molecular switches as 19F NMR/ MRI pH-responsive compounds based on chemical shift changes. Received: November 16, 2021 Accepted: February 10, 2022 Published: February 14, 2022 Letterpubs.acs.org/ac © 2022 The Authors. Published by American Chemical Society 3427 https://doi.org/10.1021/acs.analchem.1c04978 Anal. Chem. 2022, 94, 3427−3431 Downloaded via BRNO UNIV OF TECHNOLOGY on May 27, 2022 at 09:09:17 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles. The structures (Figure 1) were derived from Aprahamian’s hydrazone switch. 33 The synthesis of hydrazones 1-E,2-E, and 3-Einvolved coupling trifluoromethylanilines with ethyl pyridyl-acetate. 34 Briefly, trifluoromethylaniline in EtOH was treated with concentrated HCl and then NaNO2at 0 °Cto give trifluoromethyl-1-benzenediazonium chloride. In a separate flask, ethyl-2-pyridyl-acetate was treated at 0 °C with sodium acetate in EtOH−H2O (8:1). These two solutions were combined and stirred at 0 °C for 1 h and then overnight at RT. The resultant reaction mixture was washed with methylene chloride, and the organic fraction was washed twice with saturated sodium bicarbonate solution and dried over magnesium sulfate. The crude product was subjected to column chromatography (SiO2,CH 2Cl2−MeOH, 8:1) to give pure compounds as an orange solid (yields, 55−65%). According to X-ray crystallography, the structures were nearly planar, and H-bonding between the N−H proton and the pyridine nitrogen subunit was observed (Figure S13). The 1H NMR spectra of molecular switches (Figure 2)inCD 3CN showed a characteristic H-bonded N−H resonance around 15 ppm, in addition to the expected aromatic and aliphatic signals. The N−H chemical shift indicates that the pyridine nitrogen is H-bonded with the N−H proton. A careful look at the 1H NMR spectrum shows a small signal near 12 ppm stemming from the minor Zconfiguration. The calculated geometries (B3LYP/6-31G(d, p) level of theory) of the two configurations in CD3CN showed that the Econfiguration is more stable than Z, which is in agreement with the isomer ratio observed in the 1H NMR spectrum. The addition of 1.6 equiv of TFA to CD3CN solutions of 1-E,2-E, and 3-Eprotonated the pyridine subunit, which was accompanied by a color change in the solution from light yellow to orange (Figure 3c) and drastic changes in the 1H NMR and 19F NMR spectra (Figure 2). First, the N−H proton signals at 15 ppm disappeared, and new signals appeared at 13 ppm. This shift indicates that rotation around the CN bond has occurred (E/Zisomerization) and that the N−H proton formed a hydrogen bond with the carbonyl group of the ester subunit, yielding Z-H+. Second, the pyridine proton signals shifted upfield, which is typical for protonated pyridine rings (Figure S9). In the 19F NMR spectra, peaks from the −CF3group can be seen near −62.0 ppm. With the addition of TFA, these peaks moved toward higher frequencies for 1-Eand 3-E, and those for the 2Epeak moved toward a lower frequency. For the o-isomer (1E), the greatest change in the chemical shift was −1.8 ppm. The 19F NMR signals were sharper (8 Hz) than the N−H signals recorded by 1H NMR (25 Hz) (width at half the peak height). To better describe the switching process, the Z-H+ molar fraction was calculated (based on peak integrals) and plotted against the pH of the solution (Figure 4). It can be seen that the switching process occurred between pH 4 and 3, and the range is practically identical for all isomers. The relationship from Figure 4 can be used for determination of the pH of a solution. Within the 3−4 range, it is possible with a standard uncertainty of 0.05 pH units. Outside this range, the pH can be estimated as either >4 or <3. Figure 1. Chemical structures of fluorinated hydrazones. Figure 2. 19F NMR (left) and 1H NMR (right) spectra (400 MHz) in CD3CN; (top) 1-E(red), 2-E(green), and 3-E(blue); (bottom) ZH+recorded after the addition of 1.6 equiv of trifluoroacetic acid (TFA). Figure 3. Changes in the UV−vis spectrum during the acid/base switching of 1-E. All data were recorded in MeCN at 298 K using a 1.2 ×10−4M solution of 1-E. Spectra a and e are overlapping. Figure 4. Representation of the pH-dependent switching process. Error bars represents standard uncertainy assuming 5% accuracy of the peak integration. Analytical Chemistry pubs.acs.org/ac Letter https://doi.org/10.1021/acs.analchem.1c04978 Anal. Chem. 2022, 94, 3427−3431 3428 Upon the addition of 1.6 equiv of triethylamine (TEA) to the CD3CN solution of Z-H+, the color of the solution changed back to light yellow (Figure 3e). The 1H NMR and 19F NMR spectra (Figures S9−S11), recorded immediately after the addition of TEA, showed the complete disappearance of Z-H+and the presence of both 1-Eand 1-Zin solution. This is evident from the disappearance of the H-bonded N−H peak at 13 ppm and the appearance of two H-bonded N−H peaks (a larger one at 15 ppm and a smaller one at 12 ppm), which were assigned to Eand Z, respectively. In each case, the T1and T2relaxation times of the fluorine atom of the Eand Z-H+ isomers were 1.4−1.6 s and did not change significantly during acidification (Figures S16−S18). Such behavior greatly simplifies the imaging procedure, as only variations of chemical shifts must be taken into account. Since the pH-dependent chemical shift changes are relatively large, the compounds can be used in the MRI of pH gradients. Figure 5 shows the 19F MRI images of acetonitrile solutions (15 mM) of 1, which display the highest impact of pH on the chemical shift of the CF3functionality.Theimageswereacquiredwiththe appropriate RF excitation pulse frequency and bandwidth of 0.5 ppm to cover the resonance frequencies of the isomers (Figure 5C,E,I). The required acquisition times were 15 min and only 2 min for FLASH and RARE sequences, respectively. We were also able to perform analogous imaging with compound 3(Figure S15). Unfortunately, the difference in chemical shifts for the isomers of compound 2(0.1 ppm) turned out to be too small to register good-quality images within a reasonable time. While the chemical shift of the Z isomer showed a certain pH dependence (Figures S9−S11), the spectral distance between the 19F lines of the Eand Z isomers was large enough to obtain separate images for the entire range of pH values. If necessary, it is possible to increase the RF pulse bandwidth for MR imaging to determine the presence of the Zisomer and cover its entire pH-dependent range of chemical shifts. To explain the differences in the 19F NMR chemical shifts for the isomers 1-E,2-E, and 3-E, we performed DFT calculations to visualize their molecular orbitals. The shape of the orbitals clearly indicates an increased density of electrons in the oand p-positions (Table S2), while a much lower density was observed at the m-positions. This is due to a mesomeric effect in which the nitrogen of the hydrazone group is an electron donor to the aromatic ring. The distinct range of changes in chemical shifts in the 19F NMR spectrum during E/ Zconfiguration switching in compounds 1−3can be explained based on the differences in the binding energies of the hydrazone hydrogen. For the Econfiguration, the bond was stronger (N−H---N), and for the Zconfiguration, it was weaker (N−H---O). 35 Thus, the stronger bond polarization in the Econfiguration increased the electron-donating properties of the pyridyl nitrogen, which increased the electron density at the oand p-positions. The highest change in the chemical shift was coupled with the biggest change in energy during switching for the o-isomer, as demonstrated in Figure 6. Additionally, the −CF3group at the o-position was surrounded by strongly electronegative atoms (oxygen or nitrogen), which significantly impacted the magnetic properties of fluorine atoms. Although the Eisomers showed poor water solubility, they were highly soluble (>20−40 mg/mL) in polar organic solvents, and their protonated forms (Z-H+isomers) were slightly soluble in water (Table S5). In practical applications for 19F MRI in medical diagnostics, insoluble fluoroorganic compounds are typically used as aqueous emulsions. 36 In the case of 1, we prepared a stable vegetable oil−water emulsion with pluronic-127 as a surfactant. The emulsion showed similar features in 19F NMR and 19F MRI experiments as the acetonitrile solution, except for higher peak widths of 80 Hz compared with 8 Hz in solution (Figures S19 and S21), which are still comparable to the RF pulse bandwidths used in previous MRI experiments. In conclusion, we obtained a series of hydrazone molecular switches containing the −CF3functionality. This allowed the visualization of the switching process by 19F NMR, 1H NMR, UV−vis, and 19F MRI in the low (millimolar) concentration range with a short acquisition time in both polar organic Figure 5. 19F MRI of compound 1in CH3CN. (A,D,G) RF excitation pulse at −60.9 ppm with 0.5 ppm bandwidth; (B,E,H) RF excitation pulse at −62.7 ppm with 0.5 ppm bandwidth; (C,F,I) corresponding 19F NMR spectra. Figure 6. Calculated energy diagram for E/Zconfiguration changes of compounds 1,2, and 3. Analytical Chemistry pubs.acs.org/ac Letter https://doi.org/10.1021/acs.analchem.1c04978 Anal. Chem. 2022, 94, 3427−3431 3429 solvents or aqueous emulsions. The chemical shift changes for the 1-Eisomer were surprisingly large, which opens possibilities for applications of such molecular switches as smart MRI contrast agents. Further research is currently in progress in our laboratory to tune the pH-switching range and improve their aqueous solubility. The latter should be achieved by the introduction of polyethylene glycol or carbohydrate functionalities. 37 ■ASSOCIATED CONTENT * sıSupporting Information The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c04978. Chemicals and reagents, measurements, hardware and software configuration, sample preparation, additional experimental details, materials, and methods (PDF) ■AUTHOR INFORMATION Corresponding Author Tomasz Krawczyk −Department of Chemical Organic Technology and Petrochemistry, Silesian University of Technology, 44-100 Gliwice, Poland; orcid.org/00000002-4862-0079; Email: [email protected] Authors Dawid Janasik −Department of Chemical Organic Technology and Petrochemistry, Silesian University of Technology, 44100 Gliwice, Poland Krzysztof Jasinski −Institute of Nuclear Physics Polish Academy of Sciences, 31-342 Krakow, Poland Władysław P. Węglarz −Institute of Nuclear Physics Polish Academy of Sciences, 31-342 Krakow, Poland Ivan Nemec −Central European Institute of Technology Brno University of Technology, 612-00 Brno, Czech Republic; Department of Inorganic Chemistry, Faculty of Science, PalackyUniversity 17, 771 46 Olomouc, Czech Republic Pawel Jewula −Central European Institute of Technology Brno University of Technology, 612-00 Brno, Czech Republic Complete contact information is available at: https://pubs.acs.org/10.1021/acs.analchem.1c04978 Author Contributions Dawid Janasik: methodology, formal analysis, investigation, writing of original draft, visualization. Krzysztof Jasinski: investigation, visualization. Władysław P. Weglarz: methodology. PawełJewuła: methodology. Ivan Nemec: investigation. Tomasz Krawczyk: conceptualization, resources, writing of original draft, review and editing. Notes The authors declare no competing financial interest. ■ACKNOWLEDGMENTS We thank the Silesian University of Technology for financial support. ■DEDICATION We thank the Silesian University of Technology for the financial support (Grant 04/050/BKM21/0132) ■REFERENCES (1) Di Costanzo, L.; Panunzi, B. Molecules 2021,26 (10), 2952. (2) Monteiro, M. C. O.; Koper, M. T. M. Curr. Opin. Electrochem. 2021,25, 100649. (3) Benitz, W. Infectious Disease and Pharmacology; Elsevier, 2019. (4) Badillo, R. World J. Gastrointest. Pharmacol. Ther. 2014,5(3), 105. (5) Tannock, I. F.; Rotin, D. Cancer Res. 1989,49 (16), 4373−4384. (6) Hao, G.; Xu, Z. P.; Li, L. RSC Adv. 2018,8(39), 22182−22192. (7) Li, S.-S.; Zhang, M.; Wang, J.-H.; Yang, F.; Kang, B.; Xu, J.-J.; Chen, H.-Y. Anal. Chem. 2019,91 (13), 8398−8405. (8) Zeng, J.; Shirihai, O. S.; Grinstaff, M. W. JoLS, J. Life Sci. 2020,2 (4), 25−37. (9) Anemone, A.; Consolino, L.; Arena, F.; Capozza, M.; Longo, D. L. Cancer Metastasis Rev. 2019,38 (1−2), 25−49. (10) Pierre, V. C.; Allen, M. J.; Caravan, P. JBIC J. Biol. Inorg. Chem. 2014,19 (2), 127−131. (11) Wahsner, J.; Gale, E. M.; Rodríguez-Rodríguez, A.; Caravan, P. Chem. Rev. 2019,119 (2), 957. (12) Hequet, E.; Henoumont, C.; Muller, R. N.; Laurent, S. Future Med. Chem. 2019,11 (10), 1157−1175. (13) Janasik, D.; Krawczyk, T. Chem. Eur. J. 2022,28 (5), e202102556. (14) Peterson, K. L.; Srivastava, K.; Pierre, V. C. Front. Chem. 2018, DOI: 10.3389/fchem.2018.00160. (15) Deutsch, C. J.; Taylor, J. S. Ann. N.Y. Acad. Sci. 1987,508,33− 47. (16) Frenzel, T.; Koler, S.; Bauer, H.; Niedballa, U.; Weinmann, H. J. Investigative Radiology 1994,29, S220−S222. (17) Metcalfe, J. C.; Hesketh, T. R.; Smith, G. A. Cell Calcium 1985, 6(1−2), 183−195. (18) Oishi, M.; Sumitani, S.; Bronich, T. K.; Kabanov, A. V.; Boska, M. D.; Nagasaki, Y. Chem. Lett. 2009,38 (2), 128−129. (19) Chen, S.; Yang, Y.; Li, H.; Zhou, X.; Liu, M. Chem. Commun. 2014,50 (3), 283−285. (20) Huang, X.; Huang, G.; Zhang, S.; Sagiyama, K.; Togao, O.; Ma, X.; Wang, Y.; Li, Y.; Soesbe, T. C.; Sumer, B. D.; Takahashi, M.; Sherry, A. D.; Gao, J. Angew. Chemie Int. Ed. 2013,52 (31), 8074− 8078. (21) Li, Y.; Zhang, H.; Guo, C.; Hu, G.; Wang, L. Anal. Chem. 2020, 92 (17), 11739−11746. (22) Zhang, C.; Li, L.; Han, F. Y.; Yu, X.; Tan, X.; Fu, C.; Xu, Z. P.; Whittaker, A. K. Small 2019,15 (36), 1902309. (23) Gianolio, E.; Napolitano, R.; Fedeli, F.; Arena, F.; Aime, S. Chem. Commun. 2009,40, 6044. (24) Bonnet, C. S.; Tóth, E.Chim. Int. J. Chem. 2016,70 (1), 102− 108. (25) Aprahamian, I. Chem. Commun. 2017,53 (50), 6674−6684. (26) Harris, J. D.; Moran, M. J.; Aprahamian, I. Proc. Natl. Acad. Sci. U. S. A. 2018,115 (38), 9414−9422. (27) Feringa, B. L. Molecular Switches; Wiley VCH, 2001. (28) Nacci, C.; Baroncini, M.; Credi, A.; Grill, L. Angew. Chemie Int. Ed. 2018,57 (46), 15034−15039. (29) Arramel; Pijper, T. C.; Kudernac, T.; Katsonis, N.; van der Maas, M.; Feringa, B. L.; van Wees, B. J. Nanoscale 2013,5(19), 9277. (30) Jerca, V. V.; Hoogenboom, R. Angew. Chemie Int. Ed. 2018,57 (27), 7945−7947. (31) Wu, D.; Sedgwick, A. C.; Gunnlaugsson, T.; Akkaya, E. U.; Yoon, J.; James, T. D. Chem. Soc. Rev. 2017,46 (23), 7105−7123. (32) Xia, T.; Li, N.; Fang, X. Annu. Rev. Phys. Chem. 2013,64 (1), 459−480. (33) Landge, S. M.; Tkatchouk, E.; Benítez, D.; Lanfranchi, D. A.; Elhabiri, M.; Goddard, W. A.; Aprahamian, I. J. Am. Chem. Soc. 2011, 133 (25), 9812−9823. (34) Su, X.; Lessing, T.; Aprahamian, I. Beilstein J. Org. Chem. 2012, 8, 872−876. (35) Su, X.; Lokov, M.; Kutt, A.; Leito, I.; Aprahamian, I. Chem. Commun. 2012,48 (85), 10490. (36) Wu, L.; Liu, F.; Liu, S.; Xu, X.; Liu, Z.; Sun, X. Int. J. Nanomedicine 2020,15, 7377−7395. Analytical Chemistry pubs.acs.org/ac Letter https://doi.org/10.1021/acs.analchem.1c04978 Anal. Chem. 2022, 94, 3427−3431 3430 (37) Yu, M.; Bouley, B. S.; Xie, D.; Que, E. L. Dalt. Trans. 2019,48 (25), 9337−9341. Analytical Chemistry pubs.acs.org/ac Letter https://doi.org/10.1021/acs.analchem.1c04978 Anal. Chem. 2022, 94, 3427−3431 3431